Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Peptide Bioregulator
Also known as Ala-Glu-Asp-Leu (AEDL)
Bronchogen is the tetrapeptide Ala-Glu-Asp-Leu, a short synthetic peptide of the bioregulator class studied in research on bronchopulmonary tissue models.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Bronchogen is the tetrapeptide Ala-Glu-Asp-Leu, a short synthetic peptide of the bioregulator class studied in research on bronchopulmonary tissue models.
Experimental work examines short-peptide modulation of gene expression in cultured human cells under controlled conditions.
Third-party tested for purity, ID, quantity.
Bronchogen belongs to the family of short regulatory peptides investigated for tissue-directed activity, in this case in bronchial and lung research models. Studies of the AEDL sequence have examined epigenetic mechanisms, including effects on gene expression during cellular ageing.
The compound is a four-residue peptide, small enough that research has focused on direct peptide-DNA and peptide-chromatin interactions rather than classical receptor pharmacology.
Bronchogen arises from the Russian peptide-bioregulator research programme, which characterized a series of short tissue-directed peptides from the 1980s onward.
Subsequent work placed the AEDL sequence within a broader model of short peptides acting on gene expression and cell differentiation.
Research into the AEDL sequence centers on epigenetic regulation of gene expression in ageing human cell cultures and on peptide-directed cell differentiation. The compound-specific literature is limited relative to better-studied peptides.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Bronchogen. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$0.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
